Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Effect of first-line antituberculosis therapy on nevirapine pharmacokinetics in children younger than 3 years old.

Enimil A, Antwi S, Yang H, Dompreh A, Alghamdi WA, Gillani FS, Orstin A, Bosomtwe D, Opoku T, Norman J, Wiesner L, Langaee T, Peloquin CA, Court MH, Greenblatt DJ, Kwara A.

Antimicrob Agents Chemother. 2019 Jul 22. pii: AAC.00839-19. doi: 10.1128/AAC.00839-19. [Epub ahead of print]

PMID:
31332062
2.

Meropenem, Cefepime, and Piperacillin Protein Binding in Patient Samples.

Al-Shaer MH, Alghamdi WA, Graham E, Peloquin CA.

Ther Drug Monit. 2019 Jul 15. doi: 10.1097/FTD.0000000000000675. [Epub ahead of print]

PMID:
31318843
3.

Population pharmacokinetics of efavirenz in HIV and TB/HIV coinfected children: the significance of genotype-guided dosing.

Alghamdi WA, Antwi S, Enimil A, Yang H, Dompreh A, Wiesner L, Langaee T, Peloquin CA, Kwara A.

J Antimicrob Chemother. 2019 Sep 1;74(9):2698-2706. doi: 10.1093/jac/dkz238.

PMID:
31243456
4.

Fluoroquinolones in Drug-Resistant Tuberculosis: Culture Conversion and Pharmacokinetic/Pharmacodynamic Target Attainment To Guide Dose Selection.

Al-Shaer MH, Alghamdi WA, Alsultan A, An G, Ahmed S, Alkabab Y, Banu S, Barbakadze K, Houpt E, Kipiani M, Mikiashvili L, Cegielski JP, Kempker RR, Heysell SK, Peloquin CA.

Antimicrob Agents Chemother. 2019 Jun 24;63(7). pii: e00279-19. doi: 10.1128/AAC.00279-19. Print 2019 Jul.

5.

Cycloserine Population Pharmacokinetics and Pharmacodynamics in Patients with Tuberculosis.

Alghamdi WA, Alsultan A, Al-Shaer MH, An G, Ahmed S, Alkabab Y, Banu S, Barbakadze K, Houpt E, Kipiani M, Mikiashvili L, Schmidt S, Heysell SK, Kempker RR, Cegielski JP, Peloquin CA.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e00055-19. doi: 10.1128/AAC.00055-19. Print 2019 May.

6.

Effect of Rifampin-Isoniazid-Containing Antituberculosis Therapy on Efavirenz Pharmacokinetics in HIV-Infected Children 3 to 14 Years Old.

Kwara A, Yang H, Antwi S, Enimil A, Gillani FS, Dompreh A, Ortsin A, Opoku T, Bosomtwe D, Sarfo A, Wiesner L, Norman J, Alghamdi WA, Langaee T, Peloquin CA, Court MH, Greenblatt DJ.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01657-18. doi: 10.1128/AAC.01657-18. Print 2019 Jan.

7.

Perspectives for personalized therapy for patients with multidrug-resistant tuberculosis.

Lange C, Alghamdi WA, Al-Shaer MH, Brighenti S, Diacon AH, DiNardo AR, Grobbel HP, Gröschel MI, von Groote-Bidlingmaier F, Hauptmann M, Heyckendorf J, Köhler N, Kohl TA, Merker M, Niemann S, Peloquin CA, Reimann M, Schaible UE, Schaub D, Schleusener V, Thye T, Schön T.

J Intern Med. 2018 May 28. doi: 10.1111/joim.12780. [Epub ahead of print]

PMID:
29806961
8.

Protein Binding of First-Line Antituberculosis Drugs.

Alghamdi WA, Al-Shaer MH, Peloquin CA.

Antimicrob Agents Chemother. 2018 Jun 26;62(7). pii: e00641-18. doi: 10.1128/AAC.00641-18. Print 2018 Jul.

9.

Genome Wide Association Study Identifies the HMGCS2 Locus to be Associated With Chlorthalidone Induced Glucose Increase in Hypertensive Patients.

Singh S, McDonough CW, Gong Y, Alghamdi WA, Arwood MJ, Bargal SA, Dumeny L, Li WY, Mehanna M, Stockard B, Yang G, de Oliveira FA, Fredette NC, Shahin MH, Bailey KR, Beitelshees AL, Boerwinkle E, Chapman AB, Gums JG, Turner ST, Cooper-DeHoff RM, Johnson JA.

J Am Heart Assoc. 2018 Mar 9;7(6). pii: e007339. doi: 10.1161/JAHA.117.007339.

10.

Prevalence of attention deficit hyperactivity disorder and comorbid psychiatric and behavioral problems among primary school students in western Saudi Arabia.

AlZaben FN, Sehlo MG, Alghamdi WA, Tayeb HO, Khalifa DA, Mira AT, Alshuaibi AM, Alguthmi MA, Derham AA, Koenig HG.

Saudi Med J. 2018 Jan;39(1):52-58. doi: 10.15537/smj.2018.1.21288.

11.

Effect of a transactional model education program on coping effectiveness in women with multiple sclerosis.

Sanaeinasab H, Saffari M, Hashempour M, Karimi Zarchi AA, Alghamdi WA, Koenig HG.

Brain Behav. 2017 Sep 21;7(10):e00810. doi: 10.1002/brb3.810. eCollection 2017 Oct.

12.

Rifampin vs. rifapentine: what is the preferred rifamycin for tuberculosis?

Alfarisi O, Alghamdi WA, Al-Shaer MH, Dooley KE, Peloquin CA.

Expert Rev Clin Pharmacol. 2017 Oct;10(10):1027-1036. doi: 10.1080/17512433.2017.1366311. Epub 2017 Aug 18. Review.

PMID:
28803492
13.

Prevalence and Determinants of Hypertension and High Normal Blood Pressure Among Young Adult Saudi Females: Insights Into Preventive Strategies.

Al-Mohaissen MA, Al-Obaid QY, AlGhamdi WA, Al-Alyani HS, Dahman SM, Al-Wahhabi NA, Al-Awaji NM, Lee T.

Fam Community Health. 2017 Jul/Sep;40(3):221-230. doi: 10.1097/FCH.0000000000000154.

PMID:
28525442

Supplemental Content

Loading ...
Support Center